Sign In
Buy DXCM
$72.59
-0.180 (-0.247%)
At Close: Jun 04, 2026
Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
08:30am, Thursday, 27'th Jun 2024
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2024 financial results after market close on Thursday, July 25, 2024. Management will
Have $50K? 7 Stocks to Buy to Retire With $1 Million by 2034
06:00am, Tuesday, 25'th Jun 2024
If you are looking for millionaire-maker stocks to turn a $50,000 portfolio into $1 million in just a decade, I would like to remind you of several things. First, your portfolio would need to compou
DexCom's (DXCM) G6 CGM System Combines With AID in Netherlands
01:25pm, Friday, 21'st Jun 2024
DexCom (DXCM) announces expansion of its AID partnership in the Netherlands to offer an easier diabetes management experience.
Hype Hazards: 3 Stocks to Steer Clear of on Your Wealth-Building Journey
08:00am, Friday, 21'st Jun 2024
Searching for the next addition to your portfolio makes it easy to get caught up in the excitement surrounding the latest Wall Street darlings. Yet, not all hyped stocks have promising prospects.
Dexcom Expands AID Partnership Into The Netherlands
07:15am, Thursday, 20'th Jun 2024
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced that people living with Type 1 d
Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
06:05am, Thursday, 20'th Jun 2024
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase its expanding focus on Dexcom CGM us
The 3 Best Diabetes Stocks to Buy in June 2024
06:02am, Wednesday, 19'th Jun 2024
Since last October, there has been a marked reduction in fears about the sales of diabetes drugs dropping as a result weight-loss drugs. That's because Dexcom (NASDAQ: DXCM ) delivered stronger-than-e
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
10:50am, Tuesday, 18'th Jun 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
08:06am, Monday, 17'th Jun 2024
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DexCom's (DXCM) G7 CGM System Now Connects to Apple Watch
11:36am, Thursday, 06'th Jun 2024
DexCom (DXCM) announces the direct connectivity of its G7 CGM system to Apple Watch for users in the United States, the UK, and Ireland.
Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
06:00am, Wednesday, 05'th Jun 2024
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Mon
DexCom (DXCM) Declines on Potential Competition for Stelo (revised)
02:26pm, Tuesday, 04'th Jun 2024
DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
DexCom (DXCM) Declines on Potential Competition for Stelo
07:21am, Tuesday, 04'th Jun 2024
DexCom (DXCM) stock declined on Monday following the FDA approval of another over-the-counter glucose monitor, potentially fueling competition for Stelo.
Dexcom Wins Access to Dexcom One for 100,000 People Living With Type 2 Diabetes
07:00am, Tuesday, 04'th Jun 2024
EDINBURGH, Scotland--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, today announced a significant advancement in acc
Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
04:04pm, Monday, 03'rd Jun 2024
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, today announced that residents of
